Reported figures and Equlion model projections for the next 5 years.
Metric
2025 (actual)
2026
2027
2028
2029
2030
Trend
ROE
-620.02%
145.47%
64.11%
41.81%
31.48%
25.01%
Sector average
-19.57%
-18.86%
21.26%
45.9%
27.83%
13.61%
ROA
-32.76%
-43.93%
-48.22%
-48.05%
-48.33%
-48.05%
Sector average
-4.19%
-6.68%
-24.58%
1.77%
-29.44%
7.73%
Amounts in CHF (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as â-â. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.
Want the full financial forecast report for Santhera Pharmaceuticals Holding AG? It covers the balance sheet, income statement and Equlion model projections.
Gross Margin
19.66%
19.66%
19.66%
19.66%
19.66%
19.66%
Sector average
40.44%
40.6%
40.6%
40.6%
40.6%
40.6%
Net Margin
-63.79%
-69.54%
-66.45%
-64.55%
-63.1%
-62.2%
Total Assets
CHFÂ 148,085.00K
CHFÂ 138,940.88K
CHFÂ 154,008.83K
CHFÂ 166,102.01K
CHFÂ 177,731.60K
CHFÂ 185,751.75K
Sector average
CHFÂ 6,583,664.69K
CHFÂ 7,029,775.91K
CHFÂ 7,875,113.17K
CHFÂ 8,842,325.96K
CHFÂ 9,880,548.85K
CHFÂ 10,888,357.41K
Net Income
-CHFÂ 49,236.00K
-CHFÂ 63,044.30K
-CHFÂ 70,634.86K
-CHFÂ 76,900.23K
-CHFÂ 83,079.83K
-CHFÂ 87,325.79K
Sector average
CHFÂ 509,037.80K
CHFÂ 497,738.03K
CHFÂ 567,206.48K
CHFÂ 655,953.18K
CHFÂ 738,044.20K
CHFÂ 795,142.15K
Valuation
CHFÂ 193,022.68K
CHFÂ 247,156.15K
CHFÂ 276,913.85K
CHFÂ 301,476.32K
CHFÂ 325,702.56K
CHFÂ 342,348.23K
Sector average
CHFÂ 12,182,569.70K
CHFÂ 13,169,956.24K
CHFÂ 13,319,586.58K
CHFÂ 13,502,659.68K
CHFÂ 13,728,881.51K
CHFÂ 13,908,079.25K
Stock Price
CHFÂ 12.60
CHFÂ 16.13
CHFÂ 18.08
CHFÂ 19.68
CHFÂ 21.26
CHFÂ 22.35
Sector average
CHFÂ 102.74
CHFÂ 98.77
CHFÂ 102.59
CHFÂ 107.21
CHFÂ 112.19
CHFÂ 115.32
Santhera Pharmaceuticals Holding AG (SANN.SW) Financial Forecast | Equlion
